News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Sleep-Aligned Fasting May Support Overnight Heart Health
July 9, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Researchers found that aligning fasting with the body’s natural sleep cycle before bedtime may support cardiovascular and metabolic health.
Read Article
AMP® BGTC Announces FDA Clearance of Investigational New Drug Application for Gene Therapy Targeting Multiple Sulfatase Deficiency
July 6, 2026 - Grantee/Partner News
- Bespoke Gene Therapy Consortium (BGTC)
The FDA cleared the Investigational New Drug (IND) application for a gene therapy designed to treat children with multiple sulfatase deficiency (MSD), an ultra-rare disease.
Read ArticleNIH Announces Antiviral Drug Development Awards
May 18, 2022 - NCATS News
- Antiviral Program for Pandemics (APP)
- COVID-19
Scientists will seek to develop potential antivirals for COVID-19 and viral families with high potential to cause future pandemics.
Scientists Identify Characteristics to Better Define Long COVID
May 17, 2022 - NCATS News
- National Clinical Cohort Collaborative (N3C)
NIH-supported researchers analyzed an unprecedented collection of electronic health records (EHRs) in NCATS’ National COVID Cohort Collaborative (N3C) Data Enclave to better identify common features of long COVID. Researchers explored de-identified COVID‑19 EHR data using machine learning techniques to understand characteristics of people with long COVID and those likely to have it.
Researchers Use Cutting-Edge EHR Data Resource to Find Risk Factors for Severe COVID-19 in Children
May 11, 2022 - NCATS News
- National Clinical Cohort Collaborative (N3C)
Researchers used data from NCATS’ National COVID Cohort Collaborative Data Enclave to discover why some children with COVID-19 developed a dangerous condition called multisystem inflammatory syndrome in children, also known as MIS‑C.
Rare Disease Day at NIH 2022: Shining a Light on Patient Perspectives
May 11, 2022 - NCATS News
- Genetic and Rare Diseases (GARD) Information Center
For the second year, the annual Rare Disease Day at NIH 2022 event was held virtually due to the pandemic, but that didn’t stop patients and researchers from coming together to share their stories and highlight research efforts.
Researchers Create 3-D Model for Rare Neuromuscular Disorders, Setting Stage for Clinical Trial
April 19, 2022 - NCATS News
- Small Business (SBIR)
- Tissue Chip for Drug Screening
Partially funded by a Small Business Innovation Research grant from NCATS, Hesperos, Inc., researchers created a tissue chip model that mimics the biology of two rare neuromuscular disorders, setting the stage for testing in a clinical trial.
High-Throughput Screening Helps Advance Melanoma Therapy
March 23, 2022 - NCATS News
- Our Impact on Research Operations
Finding the right compounds for new uses in treating a disease or improving a therapeutic approach can be time consuming. To speed up the process, NCATS scientists used high-throughput screening to help advance a therapy for melanoma.